PAVmed (PAVM) Profit After Tax Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 66.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.86% |
| Sep 30, 2025 | 38.72% |
| Jun 30, 2025 | 21.55% |
| Mar 31, 2025 | 45.87% |
| Dec 31, 2024 | 4.76% |
| Jun 30, 2024 | 1.91% |
| Mar 31, 2024 | -14.59% |
| Dec 31, 2023 | -25.82% |
| Sep 30, 2023 | -58.30% |
| Jun 30, 2023 | -37.61% |
| Mar 31, 2023 | -7.40% |
| Dec 31, 2022 | -77.15% |
| Sep 30, 2022 | -103.83% |
| Jun 30, 2022 | -92.22% |
| Mar 31, 2022 | -65.77% |
| Dec 31, 2021 | -35.49% |
| Sep 30, 2021 | -61.48% |
| Jun 30, 2021 | -31.32% |
| Mar 31, 2021 | -52.95% |
| Dec 31, 2020 | -129.25% |
| Sep 30, 2020 | -2.25% |
| Jun 30, 2020 | -77.96% |
| Mar 31, 2020 | -50.22% |
| Dec 31, 2019 | -53.97% |
| Sep 30, 2019 | -16.95% |
| Jun 30, 2019 | -39.82% |
| Mar 31, 2019 | -74.52% |
| Dec 31, 2018 | -111.59% |
| Sep 30, 2018 | -81.95% |
| Jun 30, 2018 | -141.28% |
| Mar 31, 2018 | -168.27% |